Samsung and Massachusetts General Hospital Partner to Track GLP-1 Efficacy via Smartwatch Technology
Samsung Electronics and Massachusetts General Hospital (MGH) have officially launched a collaborative clinical study this month in the United States to investigate how wearable technology can monitor patients undergoing GLP-1 receptor agonist treatment. The research aims to determine if data captured by the Samsung Galaxy Watch—including body composition, physical activity, and sleep patterns—can provide meaningful…